Since approximately half of the KDM6A mutations co-occurred with the RUNX1::RUNX1T1 fusion gene, we further analyzed the RUNX1::RUNX1T1 AML in patients harboring the KDM6A mutation. This evidence concerns the gene RUNX1 and acute myeloid leukemia.